IRD

Opus Genetics Stock Analysis

AI Rating

Low
  • Quality4/10
  • Growth↓ 1/10
  • Value↓ 0/10
Opus Genetics sales and earnings growth
IRD Growth
Low
  • Revenue Y/Y↑ 29.15%
  • EPS Y/Y↑ 62.79%
  • FCF Y/Y↓ -37.84%
Opus Genetics gross and profit margin trends
IRD Profitability
Fair
  • Gross margin ↑ 100.00%
  • EPS margin↓ -349.30%
  • ROIC 5Y↑ 1281.46%
Opus Genetics net debt vs free cash flow
IRD Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -383.4

Opus Genetics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗